Lauraceae, a globally significant woody plant family, encompasses ecologically critical and economically valuable species ...

Explore the transformative field of genomics with the power to solve humanity's greatest challenges and shape the future.

BofA analyst Michael Ryskin lowered the firm’s price target on 10x Genomics (TXG) to $12 from $16 and keeps a Neutral rating on the shares.

Genomics Market Liquid Biopsy Liquid biopsy is a non-invasive method for detecting cancer by analyzing blood samples for genetic mutations ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & ...

Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...

Me has filed for bankruptcy as is seeking buyers. Here's what could happen to the company's DNA database, one of the largest ...

GenomeIndia project publishes preliminary findings from sequencing 10,000 Indian genomes, highlighting unique genetic ...

A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the Clinical ...

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science ...

Lauraceae, a globally significant woody plant family, encompasses ecologically critical and economically valuable species ...

Developed by Weill Cornell Medicine and the New York Genome Center, the approach is not only more accurate than previous ...